HAB Pharma formulations and veterinary-partner products maintain a strong, active brand presence worldwide. Explore our global footprint organized by region to easily locate the export corridor relevant to your business
Every market where Hab Pharma and its veterinary partners operate represents a commitment to high-quality healthcare formulations. Conveniently categorized by region, you can quickly find the trade corridor that fits your sourcing needs.
HAB Pharma operates an expansive global export network supplying high-quality pharmaceutical formulations and veterinary-partner products across 19+ international markets spanning 6+ key regions. The company’s longest-standing supply chains and active distribution channels are cantered in East Africa and the Middle East. Building on this strong foundation, HAB Pharma is actively extending its export presence into emerging markets across Southeast Asia and Latin America through strategic product registrations and regulatory expansions. To streamline international trade and partnerships, product offerings are organized strictly by region, enabling clients and partners to easily locate and connect with the specific market corridors that matter most to their business needs.
HAB Pharmaceuticals exports quality pharmaceutical formulations to markets across Africa, the Middle East, Asia, and beyond. Our active export corridors include Afghanistan, Kenya, Tanzania, Iraq, Yemen, Nigeria, Mauritius, Somalia, Indonesia, Cambodia, Syria, Japan, Libya, Bolivia, UAE, Turkey, Egypt, Chad, and South Sudan – with HAB Pharma formulations and veterinary-partner products carrying an active brand presence in each of these countries.
We export a diverse portfolio of pharmaceutical products, including Oral Solid Dosage forms (tablets, capsules, oral jellies, and powders), External Preparations (ointments, sprays, and gels), Ophthalmic Preparations (eye and ear drops), and Dry Powder for Injections (Beta-Lactam).
All our manufacturing units are WHO-GMP certified. In addition, our facilities hold country-specific regulatory approvals, including the Ministry of Health, Kingdom of Cambodia (Units 2 & 3); the Republic of Iraq – Ministry of Health (Unit 2); the Pharmacy and Poisons Board, Kenya (Unit 2); the Government of National Unity, Libya – Ministry of Health (Unit 2); Nigeria’s National Agency for Food and Drug Administration and Control NAFDAC (Unit 2); the Tanzania Medicines and Medical Devices Authority – TMDA (Unit 2); and the National Drug Authority, Uganda – NDA (Unit 2).
We support our international partners well beyond the point of shipment. Our regulatory team assists with dossier preparation in CTD, ACTD, or country-specific formats, along with the samples required for product registration in your target market, helping you navigate local regulatory pathways with confidence and speed.
We offers a broad and integrated manufacturing base across key pharmaceutical dosage forms. R&D capabilities further extend into complex formulations, including modified release systems, enteric coatings, and specialized delivery platforms, supporting differentiated product development.





